The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Low-activity [F]-somatostatin receptor (SSTR) imaging using [F]SiTATE on a long axial field-of-view PET/CT scanner.
Trautwein, Nils F (NF);Calderón, Eduardo (E);Linder, Pia M (PM);Reischl, Gerald (G);Driessen, Philippe (P);Lan, Wenhong (W);Brendlin, Andreas S (AS);Groß, Thorben (T);Dittmann, Helmut (H);Hinterleitner, Martina (M);Fougère, Christian la (C);Schmidt, Fabian P (FP);Kiefer, Lena S (LS);
PURPOSE: F-labelled somatostatin receptor tracers have recently gained popularity due to their better spatial resolution, longer half-life and lower costs compared to Ga-labeled tracers. The aim of this study was to evaluate the impact and limitations of reduced administered activities of [F]SiTATE on image quality, lesion detectability and quantitative PET parameters in a long axial field-of-view (LAFOV) PET/CT scanner.
METHODS: Twenty-four patients with histologically confirmed neuroendocrine tumor, who underwent clinically indicated [F]SiTATE PET/CT examination (3.0 MBq/kg, 5 min PET scan time) on a Siemens Biograph Vision Quadra LAFOV PET/CT, were included retrospectively in this study. PET list-mode data were rebinned for shorter frame durations to simulate 5 min scans with lower activities of injected radiotracer. A comparison of image reconstruction in high sensitivity (HS) and ultra-high sensitivity mode (UHS) mode was performed. Subjective image quality, noise and lesion detectability of n = 122 lesions were rated using a 5-point Likert scale. The molecular tumor volume (MTV), signal-to-noise ratio (SNR), tumor-to-liver activity concentration ratio (TLR) and standardized uptake values (SUV) were analyzed.
RESULTS: Subjective image quality decreased with simulated reduction of injected activity with generally superior ratings in the UHS mode compared to the HS mode. Despite a reduction to 1 MBq/kg of [F]SiTATE all lesions were still detected while at 0.25 MBq/kg lesion detectability decreased to 70% (HS) and 93% (UHS). Only minor changes in SUV and TLR were detected with reduced activity. However, reduced activities led to an increase in SUV, which in turn caused a decrease in SNR (at 1 MBq/kg: 7.3 in HS and 9.0 in UHS mode and an increase in deviation of the MTV.
CONCLUSION: Reducing the administered activity of injected [F]SiTATE by 66% to 1 MBq/kg (HS & UHS) is feasible in a LAFOV PET/CT scanner, maintaining clinically diagnostic image quality without statistically significant deviations in PET uptake parameters and MTV. Furthermore, in low activity [F]SiTATE PET/CT, the UHS mode improves image quality and noise as well as lesion detectability compared to HS mode, further reinforcing the clinical benefits of this recently introduced reconstruction mode.
Stay Informed!
